πŸ—žοΈ News - October 8, 2024

Β£1.2 Million Grant for AI-Driven Early Detection of Arthritis

AI-driven system aims to enhance early detection of arthritis, improving patient outcomes and reducing healthcare costs. πŸ€–πŸ’‰

🌟 Stay Updated!
Join Dr. Ailexa’s channels to receive the latest insights in health and AI.

⚑ Quick Summary

Henley Business School has secured a Β£1.2 million grant aimed at developing a machine learning platform designed to enhance the early detection and referral processes for rheumatic and musculoskeletal diseases (RMD).

πŸ’‘ Key Features and Objectives

  • πŸ” Project Name: The AI system, named RMD-Health, will be piloted at Royal Berkshire NHS Foundation Trust and Oxford University Hospitals NHS Foundation Trust between 2026 and 2027.
  • πŸ’° Funding Sources: The grant is provided by the National Institute for Health and Care Research (NIHR), the Engineering and Physical Sciences Research Council, and the Health Innovation Partnership.
  • πŸ“Š Target Population: RMD affects up to one-third of the UK population and is a significant contributor to disability.

πŸ‘©β€βš•οΈ Expert Insights

Professor Weizi (Vicky) Li, the project lead and a professor of informatics and digital health at Henley Business School, stated:

  • β€œThe annual cost of sick leave and work-related disability for rheumatoid arthritis alone is estimated at Β£1.8 billion, highlighting the urgent need for improvement in the current referral system.”
  • β€œOur machine-learning system offers a novel approach to RMD referrals, allowing for more accurate and timely patient referrals, which can lead to faster and more effective treatments.”

πŸš‘ Addressing Current Challenges

  • ⚠️ Referral Accuracy: Between 2019 and 2021, GPs had only 40% accuracy in early inflammatory arthritis referrals, placing a heavy burden on secondary care clinicians.
  • ⏳ Delays in Treatment: Current delays in referrals often lead to repeated consultations with GPs and hinder timely access to appropriate treatments.

🌟 Project Goals and Collaboration

Dr. Antoni Chan, project co-lead and consultant rheumatologist at Royal Berkshire NHS FT, emphasized:

  • β€œThis innovative project marks a significant advancement in early RMD detection and referral, promising better patient outcomes and reduced healthcare costs.”
  • β€œThe tool has shown significantly higher accuracy than existing clinical criteria during trials.”

πŸ”— Collaborative Efforts

The project involves collaboration among:

  • Henley Business School
  • Royal Berkshire NHS Foundation Trust
  • RBFT Health Data Institute
  • Oxford University Hospitals NHS Foundation Trust
  • Health Innovation Oxford
  • Integrated Care Boards across Thames Valley, Buckinghamshire, Oxfordshire, and Berkshire West
  • Patient leaders and public stakeholders

πŸ“… Future Developments

With the grant, the team anticipates being on track for regulatory approval within three years, paving the way for the integration of RMD-Health into the NHS.

πŸ”— Sources


Stay updated with the latest news in health AI & digital health tech by following our website.

Image credit: assets.henley.ac.uk

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.